Appointments: Shire, Bayer, Enterome, Cempra, Biomunex, Entasis and Pharmalink
Executive Summary
This week's roundup includes high-level appointments by Bayer, Enterome, Cempra, Innovative Medicines Canada, Renova and Pharmalink. Entasis and Nurix have also made board appointments with Shire announcing the appointment of a new head for its global genetic disease franchise.